Target intelligence / Profile preview

RNA, U7 small nuclear 56 pseudogene (RNU7-56P)

Target
RNU7-56P
Molecular classification
Other (pseudogene)
01

Overview

RNU7-56P is a pseudogene that is related to the U7 small nuclear RNA (U7 snRNA), which is a component of the U7 small nuclear ribonucleoprotein complex involved in histone pre-mRNA processing[1][4]. The RNU7-56P locus itself does not encode a functional RNA; it represents a non-functional copy within the genome[1]. RNU7-56P is classified as a pseudogene, representing a non-functional genomic locus related to the gene encoding U7 small nuclear RNA (U7 snRNA)[1]. The U7 snRNA is a small RNA molecule essential for the 3′ end processing of replication-dependent histone pre-mRNAs[4][5]. The U7 snRNA is a component of the U7 small nuclear ribonucleoprotein (U7 snRNP), which binds the histone downstream element (HDE) in pre-mRNAs to recruit the histone cleavage complex required for correct histone mRNA maturation[4][5]. While functional U7 snRNA plays a crucial role in cell cycle regulation by enabling proper histone biosynthesis~[3][4][5], RNU7-56P does not encode a functional product and has no known impact on biology or disease[1]. The functional molecule, U7 snRNA, is involved in histone RNA processing and has emerging utility in gene therapy platforms; however, RNU7-56P is a pseudogene, not a biologically active target[1][4][5]. The RNU7-56P locus does not represent a therapeutic, druggable, or biomarker target, nor is it implicated in pathology. There is an error in targeting this pseudogene for applications related to functional RNA or protein targets in research or therapy. RNU7-56P should not be considered a therapeutic or research target; there is a misassignment if used as such. For biological and therapeutic relevance, refer to the functional U7 small nuclear RNA, not this pseudogene[1].

Other names
U7.56RNU7-56P

Beyond the preview

Go deeper on RNA, U7 small nuclear 56 pseudogene (RNU7-56P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 small nuclear 56 pseudogene (RNU7-56P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call